Not recruiting
Neoplasm malignant
Not recruitingStudy on the Safety and Effectiveness of BLU-222 Alone and with Drug Combination for Patients with Advanced Solid Tumors, Including Breast and Ovarian Cancer
Registered drugNo placebo
Study on the Safety and Effectiveness of BLU-222 Alone and with Drug Combination for Patients with Advanced Solid Tumors, Including Breast and Ovarian Cancer
Registered drugNo placebo
- Disease:Neoplasm malignant
- Substances:BLU-222Carboplatin+2
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:BLU-222



